AnaptysBio, Inc.ANABNASDAQ
Loading
Interest Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+55.8%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+55.8%/yr
vs +89.1%/yr prior
Acceleration
-33.2pp
Decelerating
Percentile
P100
Near historical high
vs 3Y Ago
3.8x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$79.89M+59.5%
2024$50.09M+177.0%
2023$18.08M-14.3%
2022$21.11M+1355.7%
2021$1.45M-
2020$0.00-100.0%
2019$1.04M-37.0%
2018$1.65M-6.9%
2017$1.77M+287.6%
2016$458000.00-